v3.26.3
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Operating activities    
Net income $ 29,936 $ 36,722
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 530 592
Net amortization of investments (79) 491
Change in investment related allowance for credit losses (15) (36)
Deferred income taxes 1,257 (788)
Net realized losses (gains) on investments 144 (3,118)
Net unrealized gains on equity securities (6,267) (2,794)
Net realized losses on disposal of assets 19  
Share-based compensation 2,185 2,621
Changes in operating assets and liabilities:    
Premiums receivable, net (17,890) (25,029)
Accrued interest receivable (75) (305)
Deferred policy acquisition costs (1,298) (2,607)
Amounts held by others   (2)
Other assets (894) 966
Reserves for loss and loss adjustment expenses (27,494) (33,449)
Unearned premiums 13,234 21,649
Reinsurance balances (224) 3,118
Amounts held for others and policyholder deposits 3,508 (859)
Federal income taxes recoverable 1,428 (687)
Accounts payable and other liabilities 3,938 3,962
Net cash provided by operating activities 1,943 447
Investing activities    
Purchases of investments available-for-sale (29,506) (26,720)
Purchases of equity securities   (254)
Purchases of short-term investments (56,481) (13,077)
Proceeds from maturities of investments held-to-maturity 23,772 43,074
Proceeds from sales and maturities of investments available-for-sale 59,699 24,900
Proceeds from sales of equity securities   8,232
Proceeds from sales and maturities of short-term investments 12,077 3,504
Purchases of property and equipment (68) (1,975)
Net cash provided by investing activities 9,493 37,684
Financing activities    
Finance lease purchases (60) (63)
Share-based compensation-related tax withholding (763) (810)
Purchase of treasury stock (9,819) (4,143)
Dividends to shareholders (23,042) (22,413)
Net cash used in financing activities (33,684) (27,429)
Change in cash and cash equivalents (22,248) 10,702
Cash and cash equivalents at beginning of period 61,926 44,045
Cash and cash equivalents at end of period $ 39,678 $ 54,747